RDIF, Hetero to produce over 100 mn doses of Russian vaccine in India

Russian Direct Investment Fund (RDIF) and pharma firm Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V vaccine against COVID-19, Russia's sovereign wealth......

Omicron study: Sputnik V and Light booster effective

Russia's Sputnik V vaccine and its one-shot version Sputnik Light booster demonstrates high virus-neutralising activity (VNA) against the highly-contagious Omicron variant of COVID-19, providing a......

Russia's Sputnik Light vaccine gets phase 3 SEC trial nod

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation has  recommended the conduct of Phase III clinical trials of Russia's single dose COVID-19 vaccine......

Serum Institute to start manufacturing Sputnik vaccine in September

Serum Institute of India will start production of Sputnik vaccine at the company's facilities in September, Russian Direct Investment Fund said on Tuesday. "The first batch of Sputnik vaccine is......

Covid-19 impact: Low interest loans likely for vaccine companies

While there has been no commitment from the government on the procurement of vaccines, initial volumes, or distribution plans, there is a likelihood that the low interest loans may be made......

Russian, Indian funds to invest $1 billion in hydro power

The Russian Direct Investment Fund will team up with an Indian partner to invest $1 billion in hydroelectric projects in Asia's third-largest economy, the head of the Russian state fund told......